Skip to content
  • Twitter
  • Foursquare
Login
Enable Adherence
  • About us
    • Who we are
    • Team
    • Visual Identity
    • Stakeholders
  • Working Groups
    • WG1
    • WG2
    • WG3
    • WG4
  • Medication Adherence Technologies
  • Publications
    • Papers
    • Books & Special Issues
    • Scientific Presentations
    • Reports
    • Guidelines
    • Protocols
    • Media
  • News & Events
    • Newsletter
    • Animation video
    • Calendar
    • COST ENABLE Meetings
    • Workshops & Conferences
    • Calls
      • Training Schools
      • STSM (Short Term Scientific Missions)
      • ITC (Inclusiveness Target Countries) Conference Grants
    • FAQ
  • Contact us
  • Back to Overview

Meddox

Product and provider description
Target populations
Target condition & treatment
Adherence monitoring
Adherence support
Development and evaluation
Product and provider description
Brand name:
Meddox
Full name:
Meddox digital
Brief description:
Meddox is a medical record keeping app that enables your medical data to be stored safely and be always available. Forget about papers and lost medical records and keep all your medical history in one place.
Level of maturity:
TLR 3 or less: basic to proof of concept
Date first available:
2021-07-01
Date latest update:
2023-03-13
Current version identifier:
15.01
Types of components:
Software, Service
Usability intent:
As a stand-alone solution
Languages:
Other
Countries:
Other
T&Cs link:
Missing
Cost details:
Free
Provider name:
Meddox digital d.o.o.
Provider type:
Not-for-profit organisation?
Provider domain:
Research and/or education
Contact details:
Other – specify in next field
Details:
info@meddox.com
Target populations
Self-management use (yes/no)
No
Who interacts
Other
How many interact:
Test
Patient age group Adaptation to levels of functioning:
Infants – less than a year
Memory:
mild impairment
Perception:
mild impairment
Movement & mobility:
no impairment
Literacy:
Not specified
Health literacy:
Not specified
Comorbidity:
Not specified
Technology experience:
Not specified
Support service use (yes/no):
No
HCPs:
No
Admin:
No
Target condition & treatment
Target health condition:
Generic health relevance
preventive/therapeutic use:
Therapeutically (Medication is prescribed as treatment of a disease and its associated symptoms)?
Treatment duration:
Long-term treatment(s) (prolonged and peristently indicated therapy as it is the case in chronic, latent-progressive disease conditions.)?
Administration form:
Topical forms?
single/polypharmacy:
Polypharmacy (combination therapies)?
Dosage instructions:
Polypharmacy (combination therapies)?
Adherence monitoring / intervention:
Intervene to support medication adherence (+ comments in the next field)
Phases of adherence:
Discontinuation (when the person stops taking the medication prescribed)
Adherence monitoring
Meas methods:
Laboratory method
Targets:
outcomes
Behaviours:
symptom monitoring and management
Outcomes:
economic (indirect, direct, intangible costs)
Adherence support
Mode of delivery:
Not specified
Printed:
Other
Human interaction:
Other
Electronic:
Use of digital media (if yes, provide details below)
Smartphone/Tablet:
Other
App:
Other
Wearable electronic device:
Other
Digital media:
Other
Content:
In a digitally enabled world healthcare consumers are increasingly taking ownership and becoming more engaged in their health management. Healthcare consumers want to easily access the information they need, in order to make informed decisions about their health. Complete health records benefit individuals and improve the quality of the medical care that they receive.
Provider:
Other
Setting:
Other
telemed/telepharm:
Telepharmacy?
Development and evaluation
Open text description:
test

COST provides networking opportunities for researchers and innovators in order to strengthen Europe’s capacity to address scientific, technological and societal challenges.

Get in touch

  • Twitter
  • Foursquare

CA 19132

ENABLE - COST Action CA19132 – “European Network to Advance Best practices & technoLogy on medication adherencE”

The aim of ENABLE is to establish a network to raise awareness of adherence enhancing solutions, foster knowledge on medication adherence, accelerate clinical application of novel technologies and work collaboratively towards economically viable policy and implementation of adherence enhancing technology across healthcare systems.

Learn more

Action Details

Grant Holder: University Medical Center Groningen (UMCG), Netherlands

CSO Approval date - 24/03/2020

Start of Action - 20/10/2020

End of Action - 19/10/2024

Action email: contact@enableadherence.eu

Learn more

Useful links

  • About
  • Working Groups
  • Medication Adherence Technologies
  • Publications
  • News & Events
  • Contact us
  • Cookie policy
  • Privacy Policy

EU Flag COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

© 2023 COST CA19132